Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Tengion

Tengion
2003 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
TNGNQ STOCK SYMBOL
Description

Tengion Inc is a regenerative medicine company. The company is engaged in discovering, manufacturing and commercializing neo-organs, or products composed of living cells, with or without synthetic or natural materials, implanted or injected into the body to engraft into, regenerate, or replace a damaged tissue or organ. Its product candidates seek to eliminate the need to utilize other tissues of the body for a purpose to which they are poorly suited, procure donor organs or administer anti-rejection medications. The company's solution Neo-Kidney Augment is based on its proprietary technology, which uses tubular epithelial cells, procured by a cortical biopsy of the patient's kidney, to create an injectable product candidate that can catalyze the regeneration of functional kidney tissue.

Website
Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
PINX
Primary Office
  • 3929 Westpoint Boulevard
  • Suite G
  • Winston-Salem, NC 27103
  • United States

+1 (336) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Tengion’s full profile, request a free trial.

Tengion Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
95.4K

Tengion Financials Summary

In Thousands,
USD
TTM
30-Sep-2014
FY 2013
31-Dec-2013
FY 2012
31-Dec-2012
FY 2011
31-Dec-2011
Enterprise Value 21,804 2,588 6,175 (2,938)
Revenue 0 0 0 0
EBITDA (56,419) (11,085) (13,543) (15,124)
Net Income (64,426) (18,927) (16,929) (19,061)
Total Assets 9,621 25,724 12,435 17,817
Total Debt 34,122 26,952 11,269 4,987
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tengion Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Tengion‘s full profile, request access.

Request full access to PitchBook

Tengion Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AVM Biotechnology Venture Capital-Backed Seattle, WA 0 000.00 0000000000 0 000.00
00000000 Venture Capital-Backed South San Francisco, CA 0000 00000000000 0000
0000000 Venture Capital-Backed San Diego, CA 00 00000 00000000000 00000
00000 0000000000 Accelerator/Incubator Backed Phoenix, AZ 0000 000000000000 0000
00000000 Venture Capital-Backed Durham, NC 00 00000 000000000000 00000
To view this company’s complete list of competitors, request access »

Tengion Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Tengion‘s full profile, request access.

Request full access to PitchBook

Tengion Executive Team (12)

Name Title Board
Seat
Contact
Info
A. Davis MD Chief Financial Officer & Chief Accounting Officer
John Miclot Chief Executive Officer & Board Member
Timothy Bertram Ph.D Chief Scientific Officer & President

9 Former Executives

You’re viewing 3 of 12 executives. Get the full list »

Tengion Board Members (11)

Name Representing Role Since Contact
Info
0000-00000 000000000 00.0 Self Board Member 000 0000
00000 000000 Tengion Chairman & Board Member 000 0000
00000 00000000 00 Self Board Member 000 0000
0000 000000 Self Chief Executive Officer & Board Member 000 0000
0000000 00000 00 Self Board Member 000 0000

6 Former Board Members

You’re viewing 5 of 11 board members. Get the full list »